IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery

Completed · Not applicable · Has a placebo group

Conditions studied: Pain, Obesity

In brief

Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery. This study has the potential to confirm an opioid sparing strategy for morbid obese patients undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep apnea and the increased risk of postoperative hypoxemia make the development of opioid sparing techniques in this patient population warranted.

Key facts

Study ID

NCT01180660

Run by

Northwestern University

People needed

51

Starts

2010-06-01

Expected to finish

2012-11-01

Last updated by the study team

2014-08-07

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ASA I, II,III;
• BMI > 35 kg/m2,
• Age between 18-70,
• Fluent in English,
• Patients undergoing laparoscopic gastric bypass,
• EKG within 3 months.

You may not qualify if…

• History of allergy to local anesthetics,
• History of chronic opioid use,
• Pregnant patients,
• History of EKG abnormalities.
• Dropout: Conversion to open, patient or surgeon request.

Where it is running

• Northwestern Memorial Hospital — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.